Literature DB >> 26370511

Global Transcriptome Analysis Reveals That Poly(ADP-Ribose) Polymerase 1 Regulates Gene Expression through EZH2.

Kayla A Martin1, Matteo Cesaroni1, Michael F Denny2, Lena N Lupey1, Italo Tempera3.   

Abstract

Posttranslational modifications, such as poly(ADP-ribosyl)ation (PARylation), regulate chromatin-modifying enzymes, ultimately affecting gene expression. This study explores the role of poly(ADP-ribose) polymerase (PARP) on global gene expression in a lymphoblastoid B cell line. We found that inhibition of PARP catalytic activity with olaparib resulted in global gene deregulation, affecting approximately 11% of the genes expressed. Gene ontology analysis revealed that PARP could exert these effects through transcription factors and chromatin-remodeling enzymes, including the polycomb repressive complex 2 (PRC2) member EZH2. EZH2 mediates the trimethylation of histone H3 at lysine 27 (H3K27me3), a modification associated with chromatin compaction and gene silencing. Both pharmacological inhibition of PARP and knockdown of PARP1 induced the expression of EZH2, which resulted in increased global H3K27me3. Chromatin immunoprecipitation confirmed that PARP1 inhibition led to H3K27me3 deposition at EZH2 target genes, which resulted in gene silencing. Moreover, increased EZH2 expression is attributed to the loss of the occupancy of the transcription repressor E2F4 at the EZH2 promoter following PARP inhibition. Together, these data show that PARP plays an important role in global gene regulation and identifies for the first time a direct role of PARP1 in regulating the expression and function of EZH2.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26370511      PMCID: PMC4628063          DOI: 10.1128/MCB.00635-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.

Authors:  Adrian P Bracken; Nikolaj Dietrich; Diego Pasini; Klaus H Hansen; Kristian Helin
Journal:  Genes Dev       Date:  2006-04-17       Impact factor: 11.361

2.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

Review 3.  Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.

Authors:  D D'Amours; S Desnoyers; I D'Silva; G G Poirier
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

4.  Release of core DNA from nucleosomal core particles following (ADP-ribose)n-modification in vitro.

Authors:  G Mathis; F R Althaus
Journal:  Biochem Biophys Res Commun       Date:  1987-03-30       Impact factor: 3.575

5.  The subcellular localization of E2F-4 is cell-cycle dependent.

Authors:  G J Lindeman; S Gaubatz; D M Livingston; D Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

6.  A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen.

Authors:  Jason Moffat; Dorre A Grueneberg; Xiaoping Yang; So Young Kim; Angela M Kloepfer; Gregory Hinkle; Bruno Piqani; Thomas M Eisenhaure; Biao Luo; Jennifer K Grenier; Anne E Carpenter; Shi Yin Foo; Sheila A Stewart; Brent R Stockwell; Nir Hacohen; William C Hahn; Eric S Lander; David M Sabatini; David E Root
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

7.  Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences.

Authors:  C M Whitacre; H Hashimoto; M L Tsai; S Chatterjee; S J Berger; N A Berger
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

Review 8.  Role of poly(ADP-ribose) polymerase in cell-cycle checkpoint mechanisms following gamma-irradiation.

Authors:  M Masutani; T Nozaki; K Wakabayashi; T Sugimura
Journal:  Biochimie       Date:  1995       Impact factor: 4.079

9.  Induction of early response genes by cross-linking membrane Ig on B lymphocytes.

Authors:  P R Mittelstadt; A L DeFranco
Journal:  J Immunol       Date:  1993-06-01       Impact factor: 5.422

10.  BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiency.

Authors:  Yuqiao Shen; Farah L Rehman; Ying Feng; Julia Boshuizen; Ilirjana Bajrami; Richard Elliott; Bing Wang; Christopher J Lord; Leonard E Post; Alan Ashworth
Journal:  Clin Cancer Res       Date:  2013-07-23       Impact factor: 12.531

View more
  21 in total

1.  IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors.

Authors:  Silvia Maifrede; Kayla Martin; Paulina Podszywalow-Bartnicka; Katherine Sullivan-Reed; Samantha K Langer; Reza Nejati; Yashodhara Dasgupta; Michael Hulse; Daniel Gritsyuk; Margaret Nieborowska-Skorska; Lena N Lupey-Green; Huaqing Zhao; Katarzyna Piwocka; Mariusz A Wasik; Italo Tempera; Tomasz Skorski
Journal:  Mol Cancer Res       Date:  2017-06-20       Impact factor: 5.852

2.  ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2-/- Ovarian Cancer Cells.

Authors:  Lu Liu; Shurui Cai; Chunhua Han; Ananya Banerjee; Dayong Wu; Tiantian Cui; Guozhen Xie; Junran Zhang; Xiaoli Zhang; Eric McLaughlin; Ming Yin; Floor J Backes; Arnab Chakravarti; Yanfang Zheng; Qi-En Wang
Journal:  Mol Cancer Ther       Date:  2019-09-18       Impact factor: 6.261

Review 3.  Epstein-Barr virus: a master epigenetic manipulator.

Authors:  Rona S Scott
Journal:  Curr Opin Virol       Date:  2017-08-04       Impact factor: 7.090

Review 4.  PARP1-modulated chromatin remodeling is a new target for cancer treatment.

Authors:  Saptarshi Sinha; Sefinew Molla; Chanakya Nath Kundu
Journal:  Med Oncol       Date:  2021-08-25       Impact factor: 3.064

Review 5.  Role of NAD+ and FAD in Ischemic Stroke Pathophysiology: An Epigenetic Nexus and Expanding Therapeutic Repertoire.

Authors:  Parimala Narne; Prakash Babu Phanithi
Journal:  Cell Mol Neurobiol       Date:  2022-09-30       Impact factor: 4.231

6.  Human PARP1 Facilitates Transcription through a Nucleosome and Histone Displacement by Pol II In Vitro.

Authors:  Elena Y Kotova; Fu-Kai Hsieh; Han-Wen Chang; Natalia V Maluchenko; Marie-France Langelier; John M Pascal; Donal S Luse; Alexey V Feofanov; Vasily M Studitsky
Journal:  Int J Mol Sci       Date:  2022-06-26       Impact factor: 6.208

7.  Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1.

Authors:  Kayla A Martin; Lena N Lupey; Italo Tempera
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 8.  The Role of Poly(ADP-Ribose) Polymerase-1 in Cutaneous Wound Healing.

Authors:  Jaideep Banerjee; Niraj Lodhi; Bao-Ngoc Nguyen
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-11-06       Impact factor: 4.730

9.  EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer.

Authors:  H Yamaguchi; Y Du; K Nakai; M Ding; S-S Chang; J L Hsu; J Yao; Y Wei; L Nie; S Jiao; W-C Chang; C-H Chen; Y Yu; G N Hortobagyi; M-C Hung
Journal:  Oncogene       Date:  2017-09-18       Impact factor: 9.867

10.  PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter.

Authors:  Lena N Lupey-Green; Stephanie A Moquin; Kayla A Martin; Shane M McDevitt; Michael Hulse; Lisa B Caruso; Richard T Pomerantz; Jj L Miranda; Italo Tempera
Journal:  Virology       Date:  2017-04-26       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.